George J. Hanna

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Sarah Palmer, Frank Maldarelli, Ann Wiegand et al. · Proceedings of the National Academy of Sciences · 2008 · 641 citations · Full text

Low-level Viremia Persists, Immunology, Antiviral Drug +16

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

Frank Maldarelli, Sarah Palmer, Martin King et al. · PLoS Pathogens · 2007 · 332 citations · Full text

Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

Lee T. Bacheler, Susan Jeffrey, George J. Hanna et al. · Journal of Virology · 2001 · 238 citations · Full text

Antiretroviral resistance during successful therapy of HIV type 1 infection

Javier Martínez‐Picado, Maria Pia DePasquale, Nicholas A. Kartsonis et al. · Proceedings of the National Academy of Sciences · 2000 · 210 citations · Full text

Residual Virus Replication, Drug Resistance Mutations, Treatment And Prevention +12

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Boris Jülg, Lynda Dee, Jintanat Ananworanich et al. · The Lancet HIV · 2019 · 198 citations

Treatment And Prevention, Consensus Meeting, Clinical Trials +8